US FDA, DCG(I) explore more ways to work together
Willing to collaborate with Indian regulators, other stakeholders: US FDA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
SC stays Delhi HC order against Glenmark
Company can make, sell its brands of MSD's diabetes products till April 28
End of Wockhardt’s Chikalthana USFDA woes?
No major findings from recent USFDA inspection, after 2013 import alert on the company's Aurangabad-based Waluj and Chikalthana…
Sun Pharma closes merger deal with Ranbaxy
The combined entity’s manufacturing footprint covers five continents with products sold in over 150 nations
Biotech start ups get govt-backed equity fund
The BIRAC AcE Fund aims to accelerate growth of biotech startups
Jan Aushadhi scheme to be revamped
Faced with the under-performance of the Jan Aushadhi scheme, the government has decided to revamp the scheme
IPM registers Rs 7194 crores in February 2015
22 corporates have crossed the growth of IPM for the month of February 2015 amongst top 50
Stempeutics receives US process patent for Stempeucel
Will help patients suffering from Critical Limb Ischemia (CLI)
Novartis completes series of transactions with GlaxoSmithKline
Acquires certain oncology products and pipeline compounds from GSK
Experts laud inclusion of NCDs in draft National Health Policy
Advocate key intervention strategies to address growing burden
NSF Int’l releases GMP auditing prog
To help India’s pharmaceutical excipient manufacturers demonstrate regulatory compliance, safety and quality
DRL opens formulation development laboratory
Dr. Reddy’s Laboratories’ (DRL) Custom Pharmaceutical Services (CPS) division has expanded its existing custom service facilities…
NIPER to organise national conference on bulk drugs
Discussions will be held on opportunities for growth, challenges and way forward
Sigma Pharmaceuticals’ 7th annual conference held in Mumbai
‘Partnering for Purpose’ was the theme for this year's conference
US FDA raises concerns over Lupin’s plant at Pithampur
FDA inspected the plant in January this year and listed six observations on the manufacturing processes at the plant
Lupin and Celon in agreement
Lupin and Celon Pharma have entered into a definitive agreement under which the companies will jointly develop fluticasone/…
Zydus completes phase I studies for its oral HIF inhibitor
The multiple dosing studies are expected to be completed by Q2 2015
Intas Pharmaceuticals launches biosimilar in Europe
The product has recently been introduced under the brand Accofil
Elder Pharma launches ‘Solo’ inhalers
Forays into the Rs 800-crore nasal inhaler segment